European stocks open higher as markets anticipate first ECB rate cut since 2019; Novo Nordisk up 3.5%CNBC • 06/06/24
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough PotentialInvestorPlace • 06/05/24
Netflix, Novo Nordisk Join 3 Fashionable Breakouts; 4 IPOs In FocusInvestors Business Daily • 06/05/24
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In SpotlightInvestors Business Daily • 06/03/24
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030The Motley Fool • 06/02/24
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger Growth Driver in the Long RunThe Motley Fool • 06/02/24
Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?Investors Business Daily • 05/31/24
Fat profits from obesity? Goldman Sachs forecasts weight loss market will hit $130bn by 2030Proactive Investors • 05/31/24
Ozempic-Maker Novo Nordisk Sues Pharmacies And Weight Loss Clinics For Allegedly Selling Impure DrugsForbes • 05/30/24
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugsReuters • 05/30/24
Novo Nordisk blames middlemen in U.S. healthcare system for high prices of weight loss drugs Wegovy and OzempicMarket Watch • 05/28/24